Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers

World Journal of Gastroenterology

Volumn 20, Issue 40, 2014, Pages 14913-14920

  Niv, Yaron ^a   Boltin, Doron ^a   Halpern, Marisa ^b   Cohen, Miriam ^c   Levi, Zohar ^a   Vilkin, Alex ^a   Morgenstern, Sara ^d   Manugian, Vahig ^e   St Lawrence, Erica ^e   Gagneux, Pascal ^c   Kaur, Sukhwinder ^f   Sharma, Poonam ^g   Batra, Surinder K ^f   Ho, Samuel B ^e  

^a TEL AVIV UNIVERSITY   (Israel)

^b HASHARON HOSPITAL   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RABIN MEDICAL CENTER   (Israel)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glycosylation; Helicobacter pylori; Idiopathic ulcer; Mucin; Mucosal cytoprotection; Peptic ulcer disease

Indexed keywords

ACETYLSALICYLIC ACID; AGGLUTININ; GLYCAN; LECTIN; MUCIN 1; MUCIN 17; MUCIN 4; MUCIN 5AC; MUCIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; SIALIC ACID; STOMACH MUCIN; UNCLASSIFIED DRUG; ERYTHRINA LECTIN; MUC1 PROTEIN, HUMAN; MUC17 PROTEIN, HUMAN; MUC4 PROTEIN, HUMAN; MUCIN; N ACETYLNEURAMINIC ACID; PLANT LECTIN; POLYSACCHARIDE; RIBOSOME INACTIVATING PROTEIN; SAMBUCUS NIGRA LECTINS;

ADULT; AGED; APICAL MEMBRANE; ARTICLE; CELL PROTECTION; CELL SURFACE; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHRINA; ERYTHRINA CRISTAGALLI; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PROTEIN EXPRESSION; SAMBUCUS NIGRA; SIALYLATION; STAINING; STOMACH ULCER; ADOLESCENT; BIOPSY; CELL MEMBRANE; CHEMICALLY INDUCED; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC USE; DRUG EFFECTS; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; STOMACH; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; CELL MEMBRANE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-1; MUCIN-4; MUCINS; N-ACETYLNEURAMINIC ACID; PLANT LECTINS; POLYSACCHARIDES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RIBOSOME INACTIVATING PROTEINS; STOMACH; STOMACH ULCER; YOUNG ADULT;

EID: 84910661049     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i40.14913     Document Type: Article

References (36)

1. Boltin D, Halpern M, Levi Z, Vilkin A, Morgenstern S, Ho SB, Niv Y. Gastric mucin expression in Helicobacter pylori-related, nonsteroidal anti-inflammatory drug-related and idiopathic ulcers. World J Gastroenterol 2012; 18: 4597-4603 [PMID: 22969235 DOI: 10.3748/wjg.v18.i33.4597]
2. Niv Y. H. pylori/NSAID - negative peptic ulcer - the mucin theory. Med Hypotheses 2010; 75 : 433-435 [PMID: 20444554 DOI: 10.1016/j.mehy.2010.04.015]
3. Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Leung WK, Lau JY, Chung SC, Sung JJ. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001; 53 : 438-442 [PMID: 11275883 DOI: 10.1067/mge.2001.112840]
4. Xia HH, Wong BC, Wong KW, Wong SY, Wong WM, Lai KC, Hu WH, Chan CK, Lam SK. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001; 15: 1875-1882 [PMID: 11736717 DOI: 10.1046/j.1365-2036.2001.01115.x]
5. Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, Lai LH, Chow DK, Siu DK, Lui YN, Wu JC, To KF, Hung LC, Chan HL, Sung JJ, Chan FK. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009; 137: 525-531 [PMID: 19445937 DOI: 10.1053/j.gastro.2009.05.006]
6. Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther 2009; 30 : 791-815 [PMID: 19706147 DOI: 10.1111/j.1365-2036.2009.04105.x]
7. McColl KE. How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers. Am J Gastroenterol 2009; 104: 190-193 [PMID: 19098868 DOI: 10.1038/ajg.2008.11]
8. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 2010; 12: 319-330 [PMID: 20703838 DOI: 10.1007/s11894-010-0131-2]
9. Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 2010; 29: 2893-2904 [PMID: 20348949 DOI: 10.1038/onc.2010.87]
10. Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 2008; 70: 431-457 [PMID: 17850209 DOI: 10.1146/annurev.physiol.70.113006.100659]
11. Niv Y, Boltin D. Secreted and membrane-bound mucins and idiopathic peptic ulcer disease. Digestion 2012; 86 : 258-263 [PMID: 23075498 DOI: 10.1159/000341423]
12. Gum JR, Crawley SC, Hicks JW, Szymkowski DE, Kim YS. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 2002; 291: 466-475 [PMID: 11855812 DOI: 10.1006/bbrc.2002.6475]
13. Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 1995; 55: 2681-2690 [PMID: 7780985]
14. McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, Swierczak A, McAuley J, Harbour S, Kaparakis M, Ferrero R, Sutton P. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 2007; 133: 1210-1218 [PMID: 17919495 DOI: 10.1053/j.gastro.2007.07.003]
15. Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer 2008; 99: 949-956 [PMID: 18781152 DOI: 10.1038/sj.bjc.6604632]
16. Ho SB, Dvorak LA, Moor RE, Jacobson AC, Frey MR, Corredor J, Polk DB, Shekels LL. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 2006; 131 : 1501-1517 [PMID: 17101324 DOI: 10.1053/j.gastro.2006.09.006]
17. Luu Y, Junker W, Rachagani S, Das S, Batra SK, Heinrikson RL, Shekels LL, Ho SB. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Int J Biochem Cell Biol 2010; 42: 996-1006 [PMID: 20211273 DOI: 10.1016/j.biocel.2010.03.001]
18. Ho SB, Luu Y, Shekels LL, Batra SK, Kandarian B, Evans DB, Zaworski PG, Wolfe CL, Heinrikson RL. Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins. Biochim Biophys Acta 2010; 1800: 629-638 [PMID: 20332014 DOI: 10.1016/j.bbagen.2010.03.010]
19. Bergstrom KS, Xia L. Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology 2013; 23 : 1026-1037 [PMID: 23752712 DOI: 10.1093/glycob/cwt045]
20. Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 2002; 117: 791-796 [PMID: 12090430 DOI: 10.1309/7Y7N-M1WM-R0YK-M2VA]
21. Moniaux N, Junker WM, Singh AP, Jones AM, Batra SK. Characterization of human mucin MUC17. Complete coding sequence and organization. J Biol Chem 2006; 281: 23676-23685 [PMID: 16737958 DOI: 10.1074/jbc.M600302200]
22. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem 1987; 262: 1596-1601 [PMID: 3805045]
23. De Boeck H, Loontiens FG, Lis H, Sharon N. Binding of simple carbohydrates and some N-acetyllactosamine-containing oligosaccharides to Erythrina cristagalli agglutinin as followed with a fluorescent indicator ligand. Arch Biochem Biophys 1984; 234: 297-304 [PMID: 6548353 DOI: 10.1016/0003-9861(84)90352-7]
24. Soll AH, Vakil NB. Peptic ulcer disease: genetic, environmental, and psychological risk factors and pathogenesis. In: Feldman M, editor. UpToDate. Alphen aan den Rijn: Wolters Kluwer, 2013
25. Niv Y . MUC1 and colorectal cancer pathophysiology considerations. World J Gastroenterol 2008; 14: 2139-2141 [PMID: 18407586 DOI: 10.3748/wjg.14.2139]
26. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005; 5: 526-542 [PMID: 16069816 DOI: 10.1038/nrc1649]
27. Severi E, Hood DW, Thomas GH. Sialic acid utilization by bacterial pathogens. Microbiology 2007; 153: 2817-2822 [PMID: 17768226 DOI: 10.1099/mic.0.2007/009480-0]
28. Phillipson M, Johansson ME, Henriksnäs J, Petersson J, Gendler SJ, Sandler S, Persson AE, Hansson GC, Holm L. The gastric mucus layers: constituents and regulation of accumulation. Am J Physiol Gastrointest Liver Physiol 2008; 295: G806-G812 [PMID: 18719000 DOI: 10.1152/ajpgi.90252.2008]
29. Tsukashita S, Kushima R, Bamba M, Sugihara H, Hattori T. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001; 94: 166-170 [PMID: 11668493 DOI: 10.1002/ijc.1460]
30. Tanaka S, Mizuno M, Maga T, Yoshinaga F, Tomoda J, Nasu J, Okada H, Yokota K, Oguma K, Shiratori Y, Tsuji T. H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepatogastroenterology 2003; 50: 1739-1742 [PMID: 14571831]
31. Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, Ewoldt RH, McKinley GH, So P, Erramilli S, Bansil R. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci USA 2009; 106: 14321-14326 [PMID: 19706518 DOI: 10.1073/pnas.0903438106]
32. Kobayashi M, Lee H, Nakayama J, Fukuda M. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology 2009; 19: 453-461 [PMID: 19150806 DOI: 10.1093/glycob/cwp004]
33. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004; 305 : 1003-1006 [PMID: 15310903 DOI: 10.1126/science.1099250]
34. Lindén S, Semino-Mora C, Liu H, Rick J, Dubois A. Role of mucin Lewis status in resistance to Helicobacter pylori infection in pediatric patients. Helicobacter 2010; 15: 251-258 [PMID: 20633185 DOI: 10.1111/j.1523-5378.2010.00765.x]
35. McGuckin MA, Lindén SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011; 9: 265-278 [PMID: 21407243 DOI: 10.1038/nrmicro2538]
36. Wright CL, Kelly JK. The use of routine special stains for upper gastrointestinal biopsies. Am J Surg Pathol 2006; 30 : 357-361 [PMID: 16538056]